Literature DB >> 11861606

Lymphocyte-mediated cytotoxicity.

John H Russell1, Timothy J Ley.   

Abstract

Virtually all of the measurable cell-mediated cytotoxicity delivered by cytotoxic T lymphocytes and natural killer cells comes from either the granule exocytosis pathway or the Fas pathway. The granule exocytosis pathway utilizes perforin to traffic the granzymes to appropriate locations in target cells, where they cleave critical substrates that initiate DNA fragmentation and apoptosis; granzymes A and B induce death via alternate, nonoverlapping pathways. The Fas/FasL system is responsible for activation-induced cell death but also plays an important role in lymphocyte-mediated killing under certain circumstances. The interplay between these two cytotoxic systems provides opportunities for therapeutic interventions to control autoimmune diseases and graft vs. host disease, but oversuppression of these pathways may also lead to increased viral susceptibility and/or decreased tumor cell killing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11861606     DOI: 10.1146/annurev.immunol.20.100201.131730

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  268 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  A proteomic approach for the discovery of protease substrates.

Authors:  Andrew J Bredemeyer; Renate M Lewis; James P Malone; Alan E Davis; Julia Gross; R Reid Townsend; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

3.  Quantification of multiple gene expression in individual cells.

Authors:  António Peixoto; Marta Monteiro; Benedita Rocha; Henrique Veiga-Fernandes
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

4.  The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells.

Authors:  Sara Lind Enoksson; Emilie K Grasset; Thomas Hägglöf; Nina Mattsson; Ylva Kaiser; Susanne Gabrielsson; Tracy L McGaha; Annika Scheynius; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-01       Impact factor: 11.205

5.  Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Authors:  Alexandre Harari; Felicitas Bellutti Enders; Cristina Cellerai; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

6.  Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture.

Authors:  Hiroaki Takeda; Takeshi Kikuchi; Kyoko Soboku; Iichiro Okabe; Hiroki Mizutani; Akio Mitani; Yuichi Ishihara; Toshihide Noguchi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

7.  Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.

Authors:  Andreas A Erdmann; Zhan-Guo Gao; Unsu Jung; Jason Foley; Todd Borenstein; Kenneth A Jacobson; Daniel H Fowler
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

8.  Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection.

Authors:  Ren-Huan Xu; Min Fang; Andres Klein-Szanto; Luis J Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

9.  Determination and Quantitation of Cytotoxic T Cell-Mediated Cell Death.

Authors:  Han-Hsuan Fu; Harry Qui
Journal:  Methods Mol Biol       Date:  2021

10.  γδ T Cells Kill Plasmodium falciparum in a Granzyme- and Granulysin-Dependent Mechanism during the Late Blood Stage.

Authors:  Maria Andrea Hernández-Castañeda; Katharina Happ; Filippo Cattalani; Alexandra Wallimann; Marianne Blanchard; Isabelle Fellay; Brigitte Scolari; Nils Lannes; Smart Mbagwu; Benoît Fellay; Luis Filgueira; Pierre-Yves Mantel; Michael Walch
Journal:  J Immunol       Date:  2020-02-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.